Ecteinascidin 743 in Treating Children With Refractory Solid Tumors
NCT00006463
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
13
Enrollment
NETWORK
Sponsor class
Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG:
ECTEINASCIDIN 743
Sponsor
Children's Oncology Group
Collaborators
[object Object]